Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency

Hyperargininemia in patients with arginase 1 deficiency (ARG1‐D) is considered a key driver of disease manifestations, including spasticity, developmental delay, and seizures. Pegzilarginase (AEB1102) is an investigational enzyme therapy which is being developed as a novel arginine lowering approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz, George A., Schulze, Andreas, McNutt, Markey C., Leão‐Teles, Elisa, Merritt, J. Lawrence, Enns, Gregory M., Batzios, Spyros, Bannick, Allison, Zori, Roberto T., Sloan, Leslie S., Potts, Susan L., Bubb, Gillian, Quinn, Anthony G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359196/
https://www.ncbi.nlm.nih.gov/pubmed/33325055
http://dx.doi.org/10.1002/jimd.12343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359196/
https://www.ncbi.nlm.nih.gov/pubmed/33325055
http://dx.doi.org/10.1002/jimd.12343

Ejemplares similares